These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ANCA comes of age-but with caveats. Hamour SM; Salama AD Kidney Int; 2011 Apr; 79(7):699-701. PubMed ID: 21403654 [TBL] [Abstract][Full Text] [Related]
3. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P Front Immunol; 2021; 12():625672. PubMed ID: 33841408 [TBL] [Abstract][Full Text] [Related]
4. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study. Andreiana I; Stancu S; Avram A; Taran L; Mircescu G BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651 [TBL] [Abstract][Full Text] [Related]
5. ANCA renal risk score predicts outcome in the Manchester cohort. Li AS; Saleh C; Denley H; Patel M; Brix SR Kidney Int; 2019 Jul; 96(1):246-247. PubMed ID: 31229033 [No Abstract] [Full Text] [Related]
6. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis. Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis. Vandenbussche C; Bitton L; Bataille P; Glowacki F; Azar R; Hatron PY; Macnamara E; Gheerbrant JD; Cardon G; Hoffmann M; Auxenfants E; Gnemmi V; Quéméneur T Am J Nephrol; 2019; 49(6):479-486. PubMed ID: 31117066 [TBL] [Abstract][Full Text] [Related]
9. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759 [TBL] [Abstract][Full Text] [Related]
10. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters? Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223 [TBL] [Abstract][Full Text] [Related]
11. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome. Jabur WL; Saeed HM Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883 [TBL] [Abstract][Full Text] [Related]
12. On ANCA-associated glomerulonephritis in the very elderly. Reschen ME Kidney Int; 2011 Nov; 80(10):1107; author reply 1107. PubMed ID: 22042032 [No Abstract] [Full Text] [Related]
13. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis. Shah S; Havill J; Rahman MH; Geetha D Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939 [TBL] [Abstract][Full Text] [Related]
15. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Zhao L; David MZ; Hyjek E; Chang A; Meehan SM Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918 [TBL] [Abstract][Full Text] [Related]
16. Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre. Crnogorac M; Horvatic I; Toric L; Galesic Ljubanovic D; Tisljar M; Galesic K Int Urol Nephrol; 2017 Aug; 49(8):1419-1431. PubMed ID: 28646482 [TBL] [Abstract][Full Text] [Related]
17. A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes. Scott J; Canepa C; Buettner A; Ryan L; Moloney B; Cormican S; Walsh C; White A; Salama AD; Little MA Sci Rep; 2021 Jun; 11(1):13080. PubMed ID: 34158593 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Walsh M; Casian A; Flossmann O; Westman K; Höglund P; Pusey C; Jayne DR; Kidney Int; 2013 Aug; 84(2):397-402. PubMed ID: 23615499 [TBL] [Abstract][Full Text] [Related]
19. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis. Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C Front Immunol; 2020; 11():607261. PubMed ID: 33613528 [TBL] [Abstract][Full Text] [Related]
20. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse. Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]